Following three successful conferences in Paris, France (2015, 2016) and St. Gallen, Switzerland (2017), we are pleased to announce that the 4th International Conference for Marketing in the Insurance industry (ICMI) will be held at the Executive Business Centre, Bournemouth University on the 13th and 14th September 2018.
ICMI is the annual conference of the Association for Insurance Marketing (AIM) which serves as the primary platform to promote research in the field of insurance marketing. Though many academics have investigated marketing related topics in the financial sector, the insurance industry has largely been ignored. In addition, academic accounts of the insurance industry have generally focused on risk, investment and actuarial issues rather than marketing and consequently research that considers the idiosyncrasies of marketing in the insurance industry is urgently needed.
ICMI papers will cover a diverse range of insurance marketing topics including the challenges of multi-channel distribution; claims management and fraud; supply chains and ecosystems; and trust and big data. The programme includes papers from FoM and FMC doctoral students and also past and current students on the MSc Professional Development (Loss Adjusting) course.
Further information about the conference can be found here or contact the chair, Associate Professor, Julie Robson.











Prof Marahatta promoting BU-Nepal collaboration
3C Online Social: Research Culture, Community & Can you Guess Who? Thursday 26 March 1-2pm
Final Call: UKCGE Recognised Research Supervision Programme – Deadline Monday 16 March
Interdisciplinary research: Not straightforward?
BU academics in the news in Nepal
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease